Type 2 diabetes mellitus and risk of malignancy: is there a strategy to identify a subphenotype of patients with increased susceptibility to endogenous and exogenous hyperinsulinism?

K. Mussig, H. Staiger, K. Kantartzis, A. Fritsche, L. Kanz and H.-U. Haring

Diabetic Medicine 28 ( 3 ): 276 - 286 , 2011